Longitude Capital Partners II, LLC → Kala Pharmaceuticals, Inc. KALA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 1.17

256,622 shares short · +17.4% vs prior

Other 13D/G Filings on Kala Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-02	SCHEDULE 13D/A	Lazar David E.	3.90%	719,404	view →
2025-10-01	SCHEDULE	SR ONE CAPITAL MANAGEMENT, LLC	5.50%	411,000	view →
2022-05-25	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-04-01	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by Longitude Capital Partners II, LLC

Filed	Form	Issuer	Stake	Shares
2023-03-16	SC	Aptinyx Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →